vimarsana.com
Home
Live Updates
Atossa Therapeutics Announces Sponsored Research Agreement w
Atossa Therapeutics Announces Sponsored Research Agreement w
Atossa Therapeutics Announces Sponsored Research Agreement with Weill Cornell Medicine to Address Treatment Challenges in Triple Negative Breast Cancer
SEATTLE, July 06, 2023 -- Atossa Therapeutics, Inc. , a clinical stage biopharmaceutical company developing innovative proprietary medicines to address significant unmet needs in oncology with a...
Related Keywords
Stavross Niarchos ,
Eric Van Zanten ,
David Lyden ,
Globenewswire Inc ,
Exchange Commission ,
Nasdaq ,
Atossa Therapeutics Inc ,
Weill Cornell Medicine ,
Selective Estrogen Receptor Modulators ,
Pediatric Cardiology ,
Pediatric Physician Scientist Training Program ,
Weill Cornell ,
Chief Executive ,
Selective Estrogen Receptor Modulator ,